Kolaja Carey OConnor 4
4 · Revance Therapeutics, Inc. · Filed May 6, 2022
Insider Transaction Report
Form 4
Kolaja Carey OConnor
Director
Transactions
- Award
Common Stock
2022-05-04+6,059→ 13,027 total - Award
Stock Option (Right to buy)
2022-05-04+11,343→ 11,343 totalExercise: $18.12Exp: 2032-05-03→ Common Stock (11,343 underlying)
Footnotes (2)
- [F1]Represents an annual restricted stock award (the "RSA") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the "Compensation Policy"). The shares underlying the RSA shall vest on the one year anniversary, May 4, 2023, subject to Ms. Kolaja's Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the "Plan")) through such vesting date.
- [F2]The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Ms. Kolaja's Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy.